The crop will be divided between high THC and high CBD varieties with “recent interest [in CBD] as a potential medicine for a number of medical conditions,” NIDA said. The compound THC causes pot’s mind-altering effect; CBD doesn’t get people high.
Last year, a CBD-based drug was approved by federal regulators for two rare seizure disorders and researchers are pursuing research on it for other conditions. Others are focused on THC.
“We want to study what our patients are using,” said University of Colorado Assistant Professor Emily Lindley, who is investigating marijuana with high THC as an alternative to opioids for chronic back pain.
Lindley and other researchers want others besides the University of Mississippi to get federal authorization to grow research pot. The U.S. Drug Enforcement Administration created an application process for growers, but has not acted on more than two dozen applications. In June, Scottsdale Research
... read more at: http://the-japan-news.com/news/article/0005869298